Fibrinolytic Agents: all 366 studies that test it
Page 4 of 4. Open to participants first (56), then studies with results posted, then the rest; newest registration first within each.
- Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With InsomniaCompletedNCT00913614Phase 1
- Extending the Time for Thrombolysis in Emergency Neurological DeficitsCompletedNCT00887328Phase 3
- Urokinase Therapy in Patients With Diabetic Foot SyndromeTerminatedNCT00823225Phase 3
- Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance DifficultiesCompletedNCT00805350Phase 3
- 12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in ChinaCompletedNCT00799968Phase 4
- Argatroban Versus Lepirudin in Critically Ill PatientsTerminatedNCT00798525Phase 4
- Urokinase Versus Video-assisted Thoracoscopic to Treat Complicated Parapneumonic Empyema in ChildhoodCompletedNCT00798278Phase 3
- Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic StrokeCompletedNCT00790920Phase 3
- Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in ChinaCompletedNCT00781378Phase 4
- Parnaparin vs Aspirin in the Treatment of Retinal Vein OcclusionTerminatedNCT00732927Phase 3
- Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance DifficultiesCompletedNCT00679900Phase 3
- Safety and Efficacy of TAK-442 in Subjects With Acute Coronary SyndromesCompletedNCT00677053Phase 2
- Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee ReplacementCompletedNCT00641732Phase 2
- PEITHO Pulmonary Embolism Thrombolysis StudyCompletedNCT00639743Phase 3
- Desmoteplase in Acute Ischemic Stroke (DIAS)CompletedNCT00638781Phase 2
- Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS)CompletedNCT00638248Phase 1/2
- Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial InfarctionCompletedNCT00627809Phase 4
- IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel OcclusionCompletedNCT00624000Not applicable
- Urokinase Therapy in Diabetic Foot SyndromeCompletedNCT00537498Phase 2
- Dornase Alfa and Urokinase for Kids With Pleural EmpyemaStatus unknownNCT00502632Phase 2/3
- Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a StrokeTerminatedNCT00499902Phase 2
- Post-marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary EmbolismCompletedNCT00442234Phase 4
- Odiparcil QT Definitive StudyTerminatedNCT00437242Phase 1
- Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot StudyWithdrawnNCT00431379Phase 1
- A Dose Escalation and Safety Study of Plasmin (Human) In Acute Lower Extremity Native Artery or Bypass Graft OcclusionCompletedNCT00418483Phase 1
- Safety and Effectiveness of tPA in Intra-abdominal AbscessesTerminatedNCT00417768Phase 2/3
- Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma PatientsCompletedNCT00406978Phase 1/2
- Study to Evaluate Plasmin for the Creation of a Posterior Vitreous DetachmentTerminatedNCT00348439Phase 2
- A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)TerminatedNCT00347646Phase 1/2
- Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central CathetersCompletedNCT00346424Phase 3
- Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of SymptomsCompletedNCT00343174Phase 3
- Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for SurgeryTerminatedNCT00338585Phase 3
- Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal CancerCompletedNCT00331786Phase 1
- Safety and Efficacy Study of Alfimeprase in Subjects With Occluded CathetersCompletedNCT00322270Phase 3
- Efficacy and Safety of SR46349B in Patients With Sleep Disorders in FibromyalgiaCompletedNCT00313885Phase 2
- Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance InsomniaCompletedNCT00308503Phase 3
- Cathflo Activase Pediatric StudyCompletedNCT00307580Phase 4
- Alteplase for Blood Flow Restoration in Hemodialysis CathetersTerminatedNCT00303420Phase 4
- Effect of Complementary Intracoronary Streptokinase Administration Immediately After Primary Percutaneous Coronary Intervention on Microvascular Perfusion and Late Term Infarct Size in Patients With Acute Myocardial InfarctionCompletedNCT00302419Phase 4
- ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic StrokeTerminatedNCT00300196Phase 3
- Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic StrokeCompletedNCT00283088Phase 1
- Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of DefibrotideCompletedNCT00272948Phase 2/3
- Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and InfantsTerminatedNCT00265005Phase 1
- Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance InsomniaCompletedNCT00253968Phase 3
- Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 YearCompletedNCT00253903Phase 3
- Interventional Management of Stroke (IMS) II StudyCompletedNCT00243906Phase 2
- A Study Comparing a New Dosing Regimen of Clot-dissolving Drug for Mechanical Heart Valves Which Show ClotsCompletedNCT00232622Phase 3
- Tenecteplase Pulmonary Embolism Italian StudyTerminatedNCT00222651Phase 2
- Rt-PA Infusion Versus Catheter Exchange for Dialysis Catheter Malfunction Due to Fibrin SheathTerminatedNCT00194181Not applicable
- A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI)TerminatedNCT00168792Phase 4
- Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early NephropathyTerminatedNCT00157508Phase 2
- Thrombolysis Using Tenecteplase (Metalyse®) in Cardiac Arrest - The TROICA TrialTerminatedNCT00157261Phase 3
- Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial InfarctionCompletedNCT00148460Phase 3
- Ancrod (Viprinex™) for the Treatment of Acute, Ischemic StrokeTerminatedNCT00141011Phase 3
- Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg ArteriesCompletedNCT00115999Phase 3
- Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2)CompletedNCT00111852Phase 3
- Alteplase for Treatment of Empyema and Complicated Parapneumonic EffusionStatus unknownNCT00103766Not applicable
- Alfimeprase for Thrombolysis in Acute Peripheral Arterial OcclusionCompletedNCT00073554Phase 2
- Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access DevicesCompletedNCT00073515Phase 2
- Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access DevicesCompletedNCT00039767Phase 2
- Intraventricular Rt-PA in Patients With Intraventricular HemorrhageCompletedNCT00029315Phase 2
- Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell TransplantationCompletedNCT00003966Phase 2
- Treatment for Blood Clots in the Veins of the LegsCompletedNCT00001713Phase 1
- Intravenous Streptokinase in Acute Myocardial InfarctionCompletedNCT00000507Phase 3
- Thrombolysis in Myocardial Infarction (TIMI)CompletedNCT00000505Phase 3
- Myocardial Infarction Triage and Intervention Project (MITI)CompletedNCT00000468Phase 3